New strategy shows potential to block nerve loss in neurodegenerative diseases
Researchers at the School of Medicine are working toward a treatment for neurodegenerative diseases, among them peripheral neuropathies and Parkinson’s disease, that targets SARM1, a key molecule in the death of axons, the wiring of the nervous system.
Multi-scale imaging technique may enable objective assessment of myofascial pain
Faculty members Song Hu and Yong Wang are teaming up to find quantitative biomarkers for clinical pain management.
Biomarkers for Parkinson’s disease sought through imaging
Abhinav Jha and a group of interdisciplinary collaborators have developed a method to measure dopamine transporter, a protein related to movement and Parkinson’s disease.
Adeoye, Guilak, Gutmann, Kipnis elected to National Academy of Medicine
Washington University School of Medicine faculty members Opeolu M. Adeoye, MD, Farshid Guilak, PhD, David H. Gutmann, MD, PhD, and Jonathan Kipnis, PhD, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership is considered one of the highest honors in the health and medicine fields.
NIH grant supports Jha’s work on ethics of AI in imaging
A $314,807 grant from the National Institutes of Health (NIH) will support Abhinav Jha’s interdisciplinary work looking at the ethics of artificial intelligence implementation in the medical sphere.
WashU COVID-19 nasal vaccine technology licensed to Ocugen
Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.
Hidden microbiome fortifies animals, plants too
Pioneering research at Washington University helped people understand the fundamental role of gut microbes in human health and disease. Now a community of local scientists is learning more about the diverse microbial systems that support animals, plants and ecosystems.
Oyen and team receive funding to study placental function
An award from Wellcome Leap will support Michelle Oyen’s study of fetal growth restriction during gestational development. The program aims to reduce stillbirth rates by half.
Investigational drug for genetic form of ALS improves disease’s molecular signs
An international phase 3 clinical trial for a drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) showed that it reduced molecular signs of the fatal disease, but at six months did not improve motor control and muscle strength, according to Washington University School of Medicine researchers.
Washington University Orthopedics teams up with St. Louis CITY Soccer Club
St. Louis CITY Soccer Club has chosen physicians with Washington University Orthopedics as the club’s official team doctors and BJC HealthCare as medical services provider.
Older Stories